Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Operating Leases: 2019-2022

Historic Operating Leases for Avadel Pharmaceuticals (AVDL) over the last 4 years, with Sep 2022 value amounting to $1.0 million.

  • Avadel Pharmaceuticals' Operating Leases fell 29.73% to $1.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.0 million, marking a year-over-year decrease of 29.73%. This contributed to the annual value of $1.7 million for FY2021, which is 7.23% down from last year.
  • As of Q3 2022, Avadel Pharmaceuticals' Operating Leases stood at $1.0 million, which was down 18.76% from $1.3 million recorded in Q2 2022.
  • Avadel Pharmaceuticals' 5-year Operating Leases high stood at $4.9 million for Q1 2019, and its period low was $1.0 million during Q3 2022.
  • In the last 3 years, Avadel Pharmaceuticals' Operating Leases had a median value of $1.7 million in 2021 and averaged $1.7 million.
  • Data for Avadel Pharmaceuticals' Operating Leases shows a maximum YoY crashed of 55.89% (in 2020) over the last 5 years.
  • Over the past 4 years, Avadel Pharmaceuticals' Operating Leases (Quarterly) stood at $2.3 million in 2019, then declined by 20.66% to $1.8 million in 2020, then fell by 7.23% to $1.7 million in 2021, then decreased by 29.73% to $1.0 million in 2022.
  • Its Operating Leases stands at $1.0 million for Q3 2022, versus $1.3 million for Q2 2022 and $1.5 million for Q1 2022.